Motley Fool Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,065
Closed -$408K 125
2022
Q4
$408K Sell
7,065
-707
-9% -$43.7K 0.05% 169
2022
Q3
$731K Sell
7,772
-7,869
-50% -$1.12M 0.07% 149
2022
Q2
$3.68M Buy
15,641
+549
+4% +$184K 0.35% 67
2022
Q1
$8.3M Sell
15,092
-1,767
-10% -$1.07M 0.61% 47
2021
Q4
$11.1M Sell
16,859
-4,320
-20% -$3.3M 0.71% 45
2021
Q3
$17.8M Buy
21,179
+1,142
+6% +$1.16M 1.16% 27
2021
Q2
$25.4M Sell
20,037
-270
-1% -$305K 1.68% 14
2021
Q1
$22.3M Buy
20,307
+810
+4% +$1.07M 1.61% 14
2020
Q4
$27.8M Buy
19,497
+12,705
+187% +$13.6M 2.08% 11
2020
Q3
$4.86M Buy
6,792
+450
+7% +$327K 0.43% 61
2020
Q2
$4.44M Buy
6,342
+548
+9% +$316K 0.44% 53
2020
Q1
$2.02M Buy
5,794
+1,926
+50% +$1.36M 0.26% 70
2019
Q4
$2.43M Sell
3,868
-132
-3% -$64.5K 0.26% 73
2019
Q3
$1.34M Buy
+4,000
New +$1.28M 0.16% 90

Other funds holding CDLX

Motley Fool Asset Management's CDLX Position: Q1 2023 in Review

Motley Fool Asset Management sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 7,065 shares — an estimated $408K sold.

Motley Fool Asset Management first reported a position in CDLX in Q3 2019 and held it in 14 quarters. The position peaked at $27.8M in Q4 2020. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Motley Fool Asset Management reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Motley Fool Asset Management sold 7,065 Cardlytics shares in Q1 2023, an estimated $408K.
  • Motley Fool Asset Management first reported a position in Cardlytics in Q3 2019 and held it in 14 quarters.
  • Motley Fool Asset Management's Cardlytics position peaked at $27.8M in Q4 2020.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Motley Fool Asset Management's 13F filing for Q1 2023, filed 10 May 2023.